Rexulti 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV7L5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,385
Award facts
- Contract value 100% obligated
- $38,384.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,384.62 to AmerisourceBergen Drug Corp for the supply of REXULTI 1 MG tablets (30-count packages) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
REXULTI (brexpiprazole) is an atypical antipsychotic medication used in the treatment of schizophrenia and major depressive disorder, representing part of the broader neuropsychiatric medication portfolio that DLA procures for military treatment facilities and veteran healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability as a critical pharmaceutical distributor for Department of Defense medical supply chains, consistently delivering medications across multiple therapeutic domains through competitively awarded, firm fixed-price arrangements. This award reflects the company's ongoing role as a preferred vendor for federal pharmaceutical procurement supporting military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FV7L5?
SPE2DR26FV7L5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FV7L5 worth?
The government has obligated $38,385 on SPE2DR26FV7L5.
Is contract SPE2DR26FV7L5 an order under another contract?
Yes. SPE2DR26FV7L5 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV7L5 competed?
The extent of competition for SPE2DR26FV7L5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award